147 related articles for article (PubMed ID: 1404666)
21. The oncogenic role of MUC12 in RCC progression depends on c-Jun/TGF-β signalling.
Gao SL; Yin R; Zhang LF; Wang SM; Chen JS; Wu XY; Yue C; Zuo L; Tang M
J Cell Mol Med; 2020 Aug; 24(15):8789-8802. PubMed ID: 32596961
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
Knebelmann B; Ananth S; Cohen HT; Sukhatme VP
Cancer Res; 1998 Jan; 58(2):226-31. PubMed ID: 9443397
[TBL] [Abstract][Full Text] [Related]
23. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
Rosendahl AH; Forsberg G
Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
[TBL] [Abstract][Full Text] [Related]
24. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
Palcy S; Bolivar I; Goltzman D
J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
[TBL] [Abstract][Full Text] [Related]
25. Differential modulation of astrocyte cytokine gene expression by TGF-beta.
Benveniste EN; Kwon J; Chung WJ; Sampson J; Pandya K; Tang LP
J Immunol; 1994 Dec; 153(11):5210-21. PubMed ID: 7963576
[TBL] [Abstract][Full Text] [Related]
26. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
27. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
Tomioka H; Sato K; Maw WW; Saito H
J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of conventional and real-time RT-PCR for the quantitation of jun protooncogene mRNA and analysis of junB mRNA expression in synovial membranes and isolated synovial fibroblasts from rheumatoid arthritis patients].
Huber R; Kunisch E; Glück B; Egerer R; Sickinger S; Kinne RW
Z Rheumatol; 2003 Aug; 62(4):378-89. PubMed ID: 12928942
[TBL] [Abstract][Full Text] [Related]
29. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta.
Panek RB; Benveniste EN
J Immunol; 1995 Mar; 154(6):2846-54. PubMed ID: 7876554
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of c-myc expression by tumor necrosis factor-alpha in combination with transforming growth factor-beta or interferon-gamma with concomitant inhibition of proliferation in human cell lines.
Hori M; Kamijo R; Takeda K; Nagumo M
J Interferon Res; 1994 Apr; 14(2):49-55. PubMed ID: 8077765
[TBL] [Abstract][Full Text] [Related]
31. Expression of cytokine mRNA transcripts in renal cell carcinoma.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1998 Aug; 76(4):357-62. PubMed ID: 9723777
[TBL] [Abstract][Full Text] [Related]
32. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
34. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.
Pertovaara L; Sistonen L; Bos TJ; Vogt PK; Keski-Oja J; Alitalo K
Mol Cell Biol; 1989 Mar; 9(3):1255-62. PubMed ID: 2725496
[TBL] [Abstract][Full Text] [Related]
35. Expression of mRNA for transforming growth factors-alpha and -beta and secretion of transforming growth factor-beta by renal cell carcinoma cell lines.
Sargent ER; Gomella LG; Wade TP; Ewing MW; Kasid A; Linehan WM
Cancer Commun; 1989; 1(5):317-22. PubMed ID: 2488683
[TBL] [Abstract][Full Text] [Related]
36. Cytokine-mediated differential induction of hepatic activator protein-1 genes.
Wang S; Evers BM
Surgery; 1998 Feb; 123(2):191-8. PubMed ID: 9481405
[TBL] [Abstract][Full Text] [Related]
37. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma.
Tiggelman AM; Boers W; Linthorst C; Sala M; Chamuleau RA
J Hepatol; 1995 Sep; 23(3):307-17. PubMed ID: 8550995
[TBL] [Abstract][Full Text] [Related]
38. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma.
Song C; Jun SY; Hong JH; Ahn H
J Cancer Res Clin Oncol; 2007 Jul; 133(7):487-92. PubMed ID: 17279417
[TBL] [Abstract][Full Text] [Related]
40. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.
Autenrieth IB; Bucheler N; Bohn E; Heinze G; Horak I
Gut; 1997 Dec; 41(6):793-800. PubMed ID: 9462212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
